Sparse feature selection for classification and prediction of metastasis in endometrial cancer
Authors:
- Mehmet Eren AhsenMAMehmet Eren Ahsen
- Todd P. BorenTBTodd P. Boren
- Nitin K. SinghNSNitin K. Singh
- Burook MisganawBMBurook Misganaw
- David G. MutchDavid G. Mutch
- Kathleen N. MooreKMKathleen N. Moore
- Floor J. BackesFBFloor J. Backes
- Carolyn K. McCourtCMCarolyn K. McCourt
- Jayanthi S. LeaJLJayanthi S. Lea
- David S. MillerDavid S. Miller
- Michael A. WhiteMWMichael A. White
- Mathukumalli VidyasagarMVMathukumalli Vidyasagar
Open Access
- 27 March 2017
- journal article
- research article
- Published by Springer Nature in BMC Genomics
- Vol. 18 (S3) , 233
Abstract
Metastasis via pelvic and/or para-aortic lymph nodes is a major risk factor for endometrial cancer. Lymph-node resection ameliorates risk but is associated with significant co-morbidities. Incidence in patients with stage I disease is 4–22% but no mechanism exists to accurately predict it. Therefore, national guidelines for primary staging surgery include pelvic and para-aortic lymph node dissection for all patients whose tumor exceeds 2cm in diameter. We sought to identify a robust molecular signature that can accurately classify risk of lymph node metastasis in endometrial cancer patients. 86 tumors matched for age and race, and evenly distributed between lymph node-positive and lymph node-negative cases, were selected as a training cohort. Genomic micro-RNA expression was profiled for each sample to serve as the predictive feature matrix. An independent set of 28 tumor samples was collected and similarly characterized to serve as a test cohort. A feature selection algorithm was designed for applications where the number of samples is far smaller than the number of measured features per sample. A predictive miRNA expression signature was developed using this algorithm, which was then used to predict the metastatic status of the independent test cohort. A weighted classifier, using 18 micro-RNAs, achieved 100% accuracy on the training cohort. When applied to the testing cohort, the classifier correctly predicted 90% of node-positive cases, and 80% of node-negative cases (FDR = 6.25%). Results indicate that the evaluation of the quantitative sparse-feature classifier proposed here in clinical trials may lead to significant improvement in the prediction of lymphatic metastases in endometrial cancer patients.Keywords
This publication has 26 references indexed in Scilit:
- Control of metastatic progression by microRNA regulatory networksNature Cell Biology, 2013
- Microarray-based analysis of gene regulation by transcription factors and microRNAs in gliomaNeurological Sciences, 2012
- SVM–T-RFE: A novel gene selection algorithm for identifying metastasis-related genes in colorectal cancer using gene expression profilesBiochemical and Biophysical Research Communications, 2012
- Stability SelectionJournal of the Royal Statistical Society Series B: Statistical Methodology, 2010
- Epigenetic Repression of microRNA-129-2 Leads to Overexpression of SOX4 Oncogene in Endometrial CancerCancer Research, 2009
- Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomised studyThe Lancet, 2009
- MicroRNAs and their target messenger RNAs associated with endometrial carcinogenesisGynecologic Oncology, 2008
- Prospective assessment of lymphatic dissemination in endometrial cancer: A paradigm shift in surgical stagingGynecologic Oncology, 2008
- Regularization and Variable Selection Via the Elastic NetJournal of the Royal Statistical Society Series B: Statistical Methodology, 2005
- MicroRNAsCell, 2004